innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Leti, a CEA Tech institute, has developed non-cooled spectrometric detector that can clearly distinguish breast tumor tissue from healthy tissue in mice at a glance.
In November 2013, IPRASENSE and Leti started an exclusive research cooperation for developing cell culture monitoring techniques based on Leti-patented Lensfree imaging technology.
Iprasense's new Cytonote Counter does more than let you observe cells in culture-it assesses cell viability, providing unparalleled precision and reproducibility.
Iprasense has just released its third product, one that leverages a lensless imaging technology protected by around a dozen patents. The company’s latest offering is particularly well-suited for high-throughput cellular screening in drug discovery.
The Epicool project is investigating the use of optics to cool epileptogenic areas in the brains of epilepsy patients resistant to other treatments. A prototype implantable device is currently being developed and will be miniaturized before animal testing begins.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.